We manually examined the loci of PLCG2 and BTK, mutations that are commonly acquired in BTKi-resistant CLL, and confirmed both genes to be wild type at all timepoints. This evidence concerns the gene PLCG2 and B-cell chronic lymphocytic leukemia.